Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers.
about
Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5.Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer.Improving adenoviral vectors and strategies for prostate cancer gene therapy
P2860
Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of polymer shieldin ...... gainst human prostate cancers.
@ast
Evaluation of polymer shieldin ...... gainst human prostate cancers.
@en
type
label
Evaluation of polymer shieldin ...... gainst human prostate cancers.
@ast
Evaluation of polymer shieldin ...... gainst human prostate cancers.
@en
prefLabel
Evaluation of polymer shieldin ...... gainst human prostate cancers.
@ast
Evaluation of polymer shieldin ...... gainst human prostate cancers.
@en
P2093
P2860
P356
P1476
Evaluation of polymer shieldin ...... gainst human prostate cancers.
@en
P2093
Catherine M Crosby
Greg J Heller
Mallory A Turner
Mary E Barry
Michael A Barry
Tien V Nguyen
P2860
P356
10.1038/MTO.2015.21
P577
2016-02-03T00:00:00Z